Events
Colin Hill Discusses AI and Machine Learning in Cancer Medicine at The Hill’s Future of Healthcare Summit
Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at The Hill's inaugural Future of Healthcare Summit to discuss the impact of technology on the transformation of care. Panelists included: Justin Barad, Co-Founder and CEO, Osso VR Paul...
read more
Colin Hill Discusses AI and Machine Learning in Cancer Medicine at Milken Institute
Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at the Milken Institute Global Conference to discuss the impact of AI and machine learning on cancer medicine, including: Mike Nohaile, Senior Vice President of Strategy, Commercialization...
read more
Colin Hill speaks on AI and Machine Learning in Cancer Medicine at Milken Institute 2019 Global Conference
The panel will focus on uses of ‘artificial intelligence and machine learning’ for cancer early detection, diagnosis, drug development and clinical decision making. These technologies have the potential to accelerate our understanding of cancer at the cellular and the...
read more
Iya Khalil joins Plenary Keynote Panel on AI in Bio-IT at Bio-IT World Conference
Iya Khalil, GNS Healthcare's Chief Operating Officer and Co-founder, will be featured on the panel "AI in Practice: How New Technologies are Changing Bio-IT" at the Bio-IT World Conference on Wednesday April 17th at 8:00am. The conference is highlighting the...
read more
Colin Hill Moderates Panel on AI at Forbes Healthcare Summit
Colin Hill, GNS CEO and co-founder moderated panel at The Forbes Healthcare Summit, held November 29th. The panel, “How Smart Is Artificial Intelligence?” brought together industry leaders to discuss the potential of AI to change healthcare. Panelists included...
read more
Colin Hill featured on AI panel at 2018 Personalized Medicine Conference
Colin Hill, CEO and co-founder of GNS Healthcare participated on a panel at the 14th Annual Personalized Medicine Conference, held Wednesday, November 14th. The panel, “Automating Actionable: How Artificial Intelligence is Charting a Course for Personalized Medicine...
read more
Rock Health Enterprise Insights panel on AI in Pharma features Iya Khalil
Everyone is talking about AI and machine learning's potential for drug discovery, clinical trial management, and precision medicine. What’s less clear is how—and to what degree—these advancements will have ripple effects across the industry and for patients. Will...
read more
Iya Khalil presents at TEDx Waltham
On Thursday, June 14th GNS Co-Founder and Chief Commercial Officer Iya Khalil will give a talk entitled "Why I believe Math Will Save My Life The Second Time Around". The talk will explore the idea of using mathematics, AI, and machine learning to understand the...
read more
GNS Co-Founders Colin Hill and Iya Khalil Take Center Stage at BIO 2018
GNS Co-founders Colin Hill and Iya Khalil will address the convergence of AI and precision medicine in a pair of panel discussions at BIO 2018. Colin will be participating in a panel titled “Cutting Waste in the Link Between Big Pharma and Payers with Precision...
read moreGNS Hosts Inaugural Precision Medicine Industry Forum
The topic of artificial intelligence (AI) and how it is driving precision medicine in healthcare was the focus of the inaugural GNS Precision Medicine Industry Forum which took place May 18th in Cambridge. More than 50 attendees representing biopharma, health plans...
read more